Hebei Guangxiang Pharmaceutical Co., Ltd. takes advantage of the opportunities for coordinated development of Beijing, Tianjin and Hebei region, plans strategically at the source of the industrial chain, and implements the “one body and two wings” development strategy with an investment of 3 billion yuan to build a super large-scale specialized pharmaceutical company specializing in the production of bulk pharmaceuticals, fine pharmaceuticals, intermediate compounds and biopharmaceutical preparations.

Guangxiang Pharmaceutical is built in Cangzhou Bohai New District Biopharmaceutical Industry Park, with a total land area of over 660,000 square meters and a total construction area of 250,000 square meters. The Phase I project covers a land area of 330,000 square meters, mainly producing caffeine series, nifedipine, metronidazole, and aminophylline products. The Phase II project mainly produces pentoxifylline, Tedizolid sulfate, Urapidil, Urapidil Hydrochloride, adrenaline and other fine pharmaceutical new varieties.

Pharmaceutical's products have been exported to more than 50 countries including the United States, Britain, Germany and the Netherlands, winning the favor of many customers and becoming a major caffeine supplier in the international market.